SART3 anticorps
Aperçu rapide pour SART3 anticorps (ABIN7255932)
Antigène
Voir toutes SART3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Polyclonal Antibody
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein of human SART3 (NP_055521.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Autre désignation
- SART3
-
Sujet
- The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing.
-
Poids moléculaire
-
Observed_MW: 130 kDa
Calculated_MW: 13 kDa/41 kDa/105 kDa/109 kDa
-
ID gène
- 9733
-
UniProt
- Q15020
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Antigène
-